New eczema pill shows promise in early trial

NCT ID NCT07298395

Recruiting now Symptom relief Sponsor: Enveda Therapeutics Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 18 times

Summary

This study tests a new daily pill, ENV-294, in 60 adults with moderate-to-severe eczema (atopic dermatitis) who haven't had success with creams. For 12 weeks, participants take either the drug or a placebo and visit the clinic regularly to track skin improvement and any side effects. The goal is to see if ENV-294 can safely reduce eczema severity and area.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Enveda Investigative Site
RECRUITING

Birmingham, Alabama, 35244, United States
Enveda Investigative Site
RECRUITING

Hot Springs, Arkansas, 71913, United States
Enveda Investigative Site
RECRUITING

Beverly Hills, California, 90212, United States
Enveda Investigative Site
RECRUITING

Fremont, California, 94538, United States
Enveda Investigative Site
RECRUITING

San Diego, California, 92121, United States
Enveda Investigative Site
RECRUITING

San Diego, California, 92123, United States
Enveda Investigative Site
RECRUITING

New Albany, Indiana, 47150, United States
Enveda Investigative Site
RECRUITING

West Lafayette, Indiana, 47906, United States
Enveda Investigative Site
RECRUITING

Louisville, Kentucky, 40217, United States
Enveda Investigative Site
RECRUITING

Auburn Hills, Michigan, 48326, United States
Enveda Investigative Site
RECRUITING

Bay City, Michigan, 48706, United States
Enveda Investigative Site
RECRUITING

Clinton Township, Michigan, 48038, United States
Enveda Investigative Site
RECRUITING

Las Vegas, Nevada, 89145, United States
Enveda Investigative Site
RECRUITING

Canton, Ohio, 44718, United States
Enveda Investigative Site
RECRUITING

Mayfield Heights, Ohio, 44124, United States
Enveda Investigative Site
RECRUITING

Camp Hill, Pennsylvania, 17011, United States
Enveda Investigative Site
RECRUITING

Arlington, Texas, 76011, United States
Enveda Investigative Site
RECRUITING

Houston, Texas, 77004, United States
Enveda Investigative Site
RECRUITING

San Antonio, Texas, 78218, United States
Enveda Investigative Site
RECRUITING

Norfolk, Virginia, 23502, United States

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS (AD)